A. J. Kazimi's most recent trade in Cumberland Pharmaceuticals Inc. was a trade of 18 Common Stock done at an average price of $2.3 . Disclosure was reported to the exchange on Dec. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Dec 2025 | 18 | 5,700,903 (37%) | 0% | 2.3 | 42 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Dec 2025 | 18 | 5,700,975 (37%) | 0% | 2.3 | 42 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Dec 2025 | 18 | 5,700,957 (37%) | 0% | 2.3 | 41 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Dec 2025 | 18 | 5,700,939 (37%) | 0% | 2.3 | 41 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Dec 2025 | 18 | 5,700,921 (37%) | 0% | 2.2 | 40 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Dec 2025 | 14 | 5,701,073 (37%) | 0% | 3.3 | 46 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Dec 2025 | 14 | 5,701,059 (37%) | 0% | 2.8 | 39 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Dec 2025 | 14 | 5,701,045 (37%) | 0% | 2.5 | 35 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Dec 2025 | 14 | 5,701,031 (37%) | 0% | 2.6 | 36 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Dec 2025 | 14 | 5,701,017 (37%) | 0% | 2.6 | 36 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Dec 2025 | 14 | 5,701,003 (37%) | 0% | 2.3 | 32 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Dec 2025 | 14 | 5,700,989 (37%) | 0% | 2.4 | 34 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Dec 2025 | 10 | 5,701,093 (37%) | 0% | 4.2 | 42 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Dec 2025 | 10 | 5,701,083 (37%) | 0% | 3.7 | 37 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Dec 2025 | 8 | 5,701,148 (37%) | 0% | 4 | 32 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Dec 2025 | 8 | 5,701,140 (37%) | 0% | 4 | 32 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Dec 2025 | 8 | 5,701,132 (37%) | 0% | 4.3 | 34 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Dec 2025 | 8 | 5,701,124 (37%) | 0% | 4.3 | 34 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Dec 2025 | 8 | 5,701,116 (37%) | 0% | 4.1 | 33 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Dec 2025 | 8 | 5,701,101 (37%) | 0% | 4.3 | 34 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Dec 2025 | 7 | 5,701,155 (37%) | 0% | 3.9 | 27 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Dec 2025 | 7 | 5,701,108 (37%) | 0% | 4.3 | 30 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 03 Nov 2025 | 18 | 5,700,885 (37%) | 0% | 2.4 | 43 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 03 Nov 2025 | 18 | 5,700,867 (37%) | 0% | 2.2 | 39 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 03 Nov 2025 | 18 | 5,700,849 (37%) | 0% | 2.2 | 40 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 03 Nov 2025 | 18 | 5,700,831 (37%) | 0% | 2.1 | 38 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 03 Nov 2025 | 17 | 5,700,813 (37%) | 0% | 1.9 | 33 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 03 Nov 2025 | 17 | 5,700,796 (37%) | 0% | 2 | 34 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 03 Nov 2025 | 17 | 5,700,779 (37%) | 0% | 2 | 34 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 03 Nov 2025 | 17 | 5,700,762 (37%) | 0% | 2 | 34 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 03 Nov 2025 | 17 | 5,700,745 (37%) | 0% | 2.2 | 37 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 03 Nov 2025 | 16 | 5,700,728 (37%) | 0% | 2.1 | 34 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 03 Nov 2025 | 16 | 5,700,712 (37%) | 0% | 2.2 | 35 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 03 Nov 2025 | 16 | 5,700,696 (37%) | 0% | 2 | 32 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 03 Nov 2025 | 16 | 5,700,680 (37%) | 0% | 2.1 | 33 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 03 Nov 2025 | 16 | 5,700,664 (37%) | 0% | 2.1 | 34 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 03 Nov 2025 | 13 | 5,700,596 (37%) | 0% | 2.8 | 36 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 03 Nov 2025 | 13 | 5,700,648 (37%) | 0% | 2.2 | 28 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 03 Nov 2025 | 13 | 5,700,635 (37%) | 0% | 2.3 | 30 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 03 Nov 2025 | 13 | 5,700,622 (37%) | 0% | 2.5 | 33 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 03 Nov 2025 | 13 | 5,700,609 (37%) | 0% | 2.8 | 37 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Oct 2025 | 13 | 5,700,583 (37%) | 0% | 3.4 | 44 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Oct 2025 | 13 | 5,700,570 (37%) | 0% | 3.3 | 43 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Oct 2025 | 13 | 5,700,557 (37%) | 0% | 3.2 | 42 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Oct 2025 | 13 | 5,700,544 (37%) | 0% | 3.3 | 43 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Oct 2025 | 13 | 5,700,531 (37%) | 0% | 3.5 | 45 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Oct 2025 | 13 | 5,700,518 (37%) | 0% | 3.5 | 46 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Oct 2025 | 13 | 5,700,505 (37%) | 0% | 3.5 | 45 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Oct 2025 | 13 | 5,700,492 (37%) | 0% | 3.6 | 47 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Oct 2025 | 13 | 5,700,479 (37%) | 0% | 3.6 | 47 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Oct 2025 | 13 | 5,700,466 (37%) | 0% | 3.5 | 46 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Oct 2025 | 13 | 5,700,453 (37%) | 0% | 3.5 | 45 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Oct 2025 | 13 | 5,700,440 (37%) | 0% | 3.5 | 45 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Oct 2025 | 13 | 5,700,427 (37%) | 0% | 3.4 | 44 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Oct 2025 | 13 | 5,700,414 (37%) | 0% | 3.4 | 44 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Oct 2025 | 13 | 5,700,401 (37%) | 0% | 3.5 | 46 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Oct 2025 | 13 | 5,700,388 (37%) | 0% | 3.6 | 47 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Oct 2025 | 13 | 5,700,375 (37%) | 0% | 3.5 | 46 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Oct 2025 | 13 | 5,700,362 (37%) | 0% | 3.6 | 47 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Oct 2025 | 13 | 5,700,349 (37%) | 0% | 3.2 | 41 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Oct 2025 | 13 | 5,700,336 (37%) | 0% | 3.2 | 41 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Oct 2025 | 13 | 5,700,323 (37%) | 0% | 3.2 | 42 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Oct 2025 | 13 | 5,700,310 (37%) | 0% | 3.3 | 43 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 01 Oct 2025 | 13 | 5,700,297 (37%) | 0% | 3.3 | 43 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 02 Sep 2025 | 13 | 5,700,271 (37%) | 0% | 3.2 | 41 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 02 Sep 2025 | 13 | 5,700,284 (37%) | 0% | 3.2 | 41 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 02 Sep 2025 | 12 | 5,700,042 (37%) | 0% | 3.5 | 42 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 02 Sep 2025 | 12 | 5,700,054 (37%) | 0% | 3.6 | 43 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 02 Sep 2025 | 12 | 5,700,066 (37%) | 0% | 3.6 | 43 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 02 Sep 2025 | 12 | 5,700,078 (37%) | 0% | 3.6 | 43 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 02 Sep 2025 | 12 | 5,700,090 (37%) | 0% | 3.4 | 41 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 02 Sep 2025 | 12 | 5,700,102 (37%) | 0% | 3.4 | 41 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 02 Sep 2025 | 12 | 5,700,114 (37%) | 0% | 3.4 | 41 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 02 Sep 2025 | 12 | 5,700,126 (37%) | 0% | 3.4 | 41 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 02 Sep 2025 | 12 | 5,700,138 (37%) | 0% | 3.5 | 42 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 02 Sep 2025 | 12 | 5,700,150 (37%) | 0% | 3.5 | 42 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 02 Sep 2025 | 12 | 5,700,162 (37%) | 0% | 3.5 | 42 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 02 Sep 2025 | 12 | 5,700,174 (37%) | 0% | 3.4 | 41 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 02 Sep 2025 | 12 | 5,700,186 (37%) | 0% | 3.3 | 40 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 02 Sep 2025 | 12 | 5,700,198 (37%) | 0% | 3.3 | 40 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 02 Sep 2025 | 12 | 5,700,210 (37%) | 0% | 3.3 | 39 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 02 Sep 2025 | 12 | 5,700,222 (37%) | 0% | 3.3 | 39 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 02 Sep 2025 | 12 | 5,700,234 (37%) | 0% | 3.1 | 37 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 02 Sep 2025 | 12 | 5,700,246 (37%) | 0% | 3.1 | 37 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | 02 Sep 2025 | 12 | 5,700,258 (37%) | 0% | 3.1 | 37 | Common Stock | |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.46 per share. | 01 Aug 2025 | 13 | 5,699,781 (37%) | 0% | 3.5 | 45 | Common Stock |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.46 per share. | 01 Aug 2025 | 13 | 5,700,030 (37%) | 0% | 3.5 | 45 | Common Stock |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.46 per share. | 01 Aug 2025 | 13 | 5,700,017 (37%) | 0% | 3.5 | 45 | Common Stock |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.46 per share. | 01 Aug 2025 | 13 | 5,700,004 (37%) | 0% | 3.5 | 45 | Common Stock |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.38 per share. | 01 Aug 2025 | 13 | 5,699,991 (37%) | 0% | 3.4 | 44 | Common Stock |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.31 per share. | 01 Aug 2025 | 13 | 5,699,978 (37%) | 0% | 3.3 | 43 | Common Stock |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.31 per share. | 01 Aug 2025 | 13 | 5,699,965 (37%) | 0% | 3.3 | 43 | Common Stock |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.23 per share. | 01 Aug 2025 | 13 | 5,699,952 (37%) | 0% | 3.2 | 42 | Common Stock |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.23 per share. | 01 Aug 2025 | 13 | 5,699,937 (37%) | 0% | 3.2 | 42 | Common Stock |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.08 per share. | 01 Aug 2025 | 13 | 5,699,924 (37%) | 0% | 3.1 | 40 | Common Stock |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.00 per share. | 01 Aug 2025 | 13 | 5,699,911 (37%) | 0% | 3 | 39 | Common Stock |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.85 per share. | 01 Aug 2025 | 13 | 5,699,898 (37%) | 0% | 2.8 | 37 | Common Stock |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.92 per share. | 01 Aug 2025 | 13 | 5,699,885 (37%) | 0% | 2.9 | 38 | Common Stock |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.92 per share. | 01 Aug 2025 | 13 | 5,699,872 (37%) | 0% | 2.9 | 38 | Common Stock |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.85 per share. | 01 Aug 2025 | 13 | 5,699,859 (37%) | 0% | 2.8 | 37 | Common Stock |
| Cumberland Pharma Inc | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.38 per share. | 01 Aug 2025 | 13 | 5,699,846 (37%) | 0% | 3.4 | 44 | Common Stock |